University of Maryland Program

Program Identity & Fit

This is a university-based, NCI-designated comprehensive cancer center program built around the University of Maryland Greenebaum Comprehensive Cancer Center, offering residents exposure to the full breadth of modern radiation oncology modalities including proton therapy, hyperthermia, brachytherapy, and radiopharmaceutical therapy across two academic sites and six community-based satellite clinics staffed by the same faculty. The department is a national leader in NCI NCTN clinical trial accrual and holds a distinctive institutional investment in FLASH radiotherapy research, spanning electron and proton FLASH platforms, small-animal image-guided studies, and translational radiobiology through its Division of Translational Radiation Sciences. Research infrastructure is substantial and central to departmental identity, with a dedicated $1.8 million self-funded FLASH initiative, named labs, and a Master Research Agreement with Varian, suggesting residents are expected to engage meaningfully with investigator-initiated and cooperative group trials rather than research being a peripheral add-on. The multi-site community network alongside a tertiary academic hub indicates the program values residents comfortable moving between high-acuity academic oncology and distributed community-based practice.